Search results
Pfizer Settles Zantac Lawsuits, Agrees To $250M Settlement To Reduce Liability: Report - Pfizer...
Benzinga· 8 hours agoIn a bid to settle thousands of lawsuits over its discontinued heartburn drug Zantac, Pfizer Inc. ...
Pfizer, AstraZeneca, Sanofi And Mainz Biomed To Uplevel Europe's Pharma Game
Benzinga via Yahoo Finance· 21 minutes agoOn Sunday, Pfizer (NYSE: PFE) and AstraZeneca Plc (NASDAQ: AZN) were among the pharmaceutical...
2 Top Growth Stocks Down 24% and 50% to Buy With $100
Motley Fool via Yahoo Finance· 1 hour agoIf you have even $100 to invest in stocks right now, here are two top healthcare companies that the...
Want $1,000 in Dividend Income? Here's How Much You'd Have to Invest in Pfizer Stock
Motley Fool via Yahoo Finance· 3 days agoPfizer (NYSE: PFE) stock has struggled over the past year, losing around 28% of its value. Its...
Vepdegestrant shows promise in breast cancer trial By Investing.com
Investing.com· 5 hours agoArvinas, Inc. (NASDAQ: ARVN) and Pfizer Inc. (NYSE: NYSE:PFE) today announced continued positive...
Pfizer offers up to $250 million to settle Zantac cancer lawsuits, FT reports By Reuters
Investing.com· 11 hours agoThe settlement was disclosed in a court filing in Delaware last week, and is aimed at reducing...
Pharma Stock Roundup: PFE DMD Study Patient Death, FDA Panel Meet for LLY's Donanemab
Zacks via Yahoo Finance· 6 days agoPfizer (PFE) reports the death of a participant in a mid-stage study of its Duchenne drug. An FDA...
Decoding Pfizer Inc (PFE): A Strategic SWOT Insight
GuruFocus.com via Yahoo Finance· 6 days agoOpportunities emphasize potential growth in emerging markets and R&D advancements. Threats include intense competition and regulatory pressures. On May...
Pfizer's next move: Can it break above $30? | Invezz
Invezz· 3 days agoPfizer Inc. (NYSE:PFE) faced a challenging 2023 in the stock market, with its shares plummeting from over $50 to a low of $25. On May 1, 2024, Pfizer...
Investing in Pfizer Inc.
Knox Daily· 3 days agoIn the deal valued at $26.47 per share,3,000 shares were bought. As a result of this transaction, Gottlieb Scott now holds 9,000 shares worth roughly $0.25 million. Argus downgraded its Pfizer ...
